Back
Anixa Biosciences, Inc. 10K Form
Sell
27
ANIX
Anixa Biosciences, Inc.
Last Price:
$4.98
Seasonality Move:
8.28%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-09-08 | 10Q | ANIX/Anixa Biosciences, Inc. Quarterly |
| 2020-06-09 | 10Q | ANIX/Anixa Biosciences, Inc. Quarterly |
| 2020-03-09 | 10Q | ANIX/Anixa Biosciences, Inc. Quarterly |
| 2020-01-10 | 10K | ANIX/Anixa Biosciences, Inc. Annual |
| 2020-01-09 | 10K | ANIX/Anixa Biosciences, Inc. Annual |
| 2019-09-06 | 10Q | ANIX/Anixa Biosciences, Inc. Quarterly |
Receive ANIX News And Ratings
See the #1 stock for the next 7 days that we like better than ANIX
ANIX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-1.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.51 |
| Price / Book: | 9.5 |
Profitability
| EPS (TTM): | -0.34460 |
|---|---|
| Net Income (TTM): | $-11.2M |
| Gross Margin: | $-37K |
| Return on Equity: | -64.77% |
| Return on Assets: | -57.22% |
Anixa Biosciences, Inc. Earnings Forecast
Key Anixa Biosciences, Inc. Financial Ratios
-
Per Share Earnings over the last 41 years have been positive in 17 years.
Anixa Biosciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ANIX |
| CUSIP: | 03528H |
| Website: | anixa.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 8.45 |
| Quick Ratio: | 7.76 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ANIX Technical Analysis vs Fundamental Analysis
Sell
27
Anixa Biosciences, Inc. (ANIX)
is a Sell
Is Anixa Biosciences, Inc. a Buy or a Sell?
-
Anixa Biosciences, Inc. stock is rated a SellThe current Anixa Biosciences, Inc. [ANIX] share price is $4.79. The Score for ANIX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.